Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trialZhiCheng Lai, Ming Shi, YaoJun Zhang et al.|European Journal of Cancer|2022Cited by 154
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular CarcinomaYu-Jie Xu, QiJiong Li, ZhiCheng Lai et al.|Technology in Cancer Research & Treatment|2021Cited by 34
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular CarcinomaRun-Bin Liang, Ming Shi, Yang Zhao et al.|Frontiers in Oncology|2021Cited by 20
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective TrialsYeXing Huang, Anna Kan, Lihong Zhang et al.|Technology in Cancer Research & Treatment|2022Cited by 8